| 1/27/2026 | BKCVDDEMIGPV | Market Commentary: Euro junk primary active; United Air holds premium; software, health care names pressured
|
| 1/26/2026 | BKHY | Fitch gives Cheplapharm notes B+
|
| 1/26/2026 | BKHY | S&P rates Cheplapharm notes B
|
| 1/26/2026 | BKHY | Moody's assigns Cheplapharm notes B3
|
| 6/16/2025 | BKHY | Moody's gives Cheplapharm notes B3
|
| 12/18/2024 | BKHY | Fitch pares Cheplapharm
|
| 12/13/2024 | BKHY | S&P pares Cheplapharm
|
| 12/10/2024 | BKHY | Moody’s pares Cheplapharm
|
| 4/25/2023 | BKHY | Moody’s assigns B2 to Cheplapharm notes
|
| 4/24/2023 | BKCVDDEMIGPV | Market Commentary: Tekni-Plex starts roadshow; Kedrion/Kevlar under pressure; Allwyn at premium
|
| 11/4/2022 | BKHY | S&P ups Cheplapharm
|
| 2/7/2022 | BKHY | Moody's assigns Cheplapharm loan B2
|
| 2/7/2022 | BKHY | Fitch rates Cheplapharm loan BB-
|
| 1/18/2022 | BKHY | Fitch puts Cheplapharm on positive watch
|
| 1/18/2022 | BKHY | S&P puts Cheplapharm on positive watch
|
| 12/20/2021 | BKHY | Moody's turns Cheplapharm view to stable
|
| 10/7/2020 | BKHY | Moody’s alters Cheplapharm view to negative
|
| 10/6/2020 | BKHY | Moody’s rates Cheplapharm notes B2
|
| 10/5/2020 | BKHY | S&P gives Cheplapharm notes B
|
| 1/24/2020 | BK | Moody's rates Cheplapharm loan, notes B2
|
| 1/24/2020 | BKHY | S&P assigns Cheplapharm loan, notes B
|
| 1/24/2020 | BKHY | S&P assigns Cheplapharm loan, notes B
|
| 1/23/2020 | BKHY | Fitch rates Cheplapharm notes BB-
|
| 10/7/2019 | BK | Moody’s cuts Cheplapharm, view to stable
|
| 6/10/2019 | BK | Market Commentary: Nuvei Technologies sets talk; Electronics for Imaging kicks off $1.1 billion two-part deal
|
| 6/10/2019 | BK | Cheplapharm cuts discount on €980 million term B-3, accelerates timing
|
| 6/5/2019 | BK | Fitch rates Cheplapharm loans BB-
|
| 5/29/2019 | BK | Cheplapharm launches €980 million term B-3 at Euribor plus 400 bps
|
| 5/28/2019 | BK | Moody's rates Cheplapharm loan B1, negative view
|
| 5/28/2019 | BK | Cheplapharm to launch €980 million term loan B-3 on Wednesday
|
| 11/16/2018 | BK | Cheplapharm finalizes €300 million add-on term B-2 at par issue price
|
| 11/7/2018 | BK | Cheplapharm shops €300 million add-on term loan B-2 at 99.75-par OID
|
| 11/6/2018 | BK | S&P rates Cheplapharm Arzneimittel loan B
|
| 11/6/2018 | BK | Moody's rates Chelapharm loan B1
|
| 11/2/2018 | BK | Cheplapharm to launch €300 million add-on term loan B-2 on Tuesday
|
| 8/10/2018 | BK | S&P gives Cheplapharm, loan B
|
| 6/28/2018 | BK | Cheplapharm flexes term B-1 to Euribor plus 450 bps, drops B-2 plans
|
| 6/7/2018 | BK | Moody’s rates Cheplapharm, loans B1
|
| 6/7/2018 | BK | S&P rates Cheplapharm loans B
|
